Induction of nitric oxide synthase in macrophages: inhibition by fructose-1,6-diphosphate.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1998-02-24

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/BBRC.1998.8163PMID 9500992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenously produced peroxynitrite induces the oxidation of mitochondrial and nuclear proteins in immunostimulated macrophages

  1997cited by this paper
• Measurements of total plasma nitrite and nitrate in pediatric patients with the systemic inflammatory response syndrome.

  1997cited by this paper
• BENEFICIAL VERSUS DETRIMENTAL EFFECTS OF NITRIC OXIDE SYNTHASE INHIBITORS IN CIRCULATORY SHOCK LESSONS LEARNED FROM EXPERIMENTAL AND CLINICAL STUDIES

  1997cited by this paper
• Hemodynamic effects of fructose 1,6-diphosphate in patients with normal and impaired left ventricular function.

  1997cited by this paper
• Post‐transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines

  1997cited by this paper
• The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide.

  1996cited by this paper
• Nitric oxide in sepsis.

  1996cited by this paper
• Fructose-1,6-bisphosphate after hypoxic ischemic injury is protective to the neonatal rat brain.

  1996cited by this paper
• Inducible Nitric Oxide Synthase Requires Both the Canonical Calmodulin-binding Domain and Additional Sequences in Order to Bind Calmodulin and Produce Nitric Oxide in the Absence of Free Ca2+*

  1996cited by this paper
• Beneficial effect of fructose-1,6-bisphosphate on mitochondrial function during ischemia-reperfusion of rat liver.

  1995cited by this paper
• Nitric oxide-related oxidants in acute lung injury.

  1995cited by this paper
• Effects of a nitric oxide synthase inhibitor in humans with septic shock.

  1994cited by this paper
• Nitric oxide reduces early growth response-1 gene expression in rat lung macrophages treated with interferon-gamma and lipopolysaccharide.

  1994cited by this paper
• Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.

  1994cited by this paper
• Metabolism of exogenously applied fructose 1,6-bisphosphate in hypoxic vascular smooth muscle.

  1994cited by this paper
• The high‐output nitric oxide pathway: role and regulation

  1994cited by this paper
• Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury.

  1994cited by this paper
• Calcium-induced cytotoxicity in hepatocytes after exposure to extracellular ATP is dependent on inorganic phosphate. Effects on mitochondrial calcium.

  1993cited by this paper
• Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages.

  1993cited by this paper
• Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization.

  1993cited by this paper
• Gram-negative sepsis and the adult respiratory distress syndrome.

  1992cited by this paper
• Preserving effect of fructose-1,6-bisphosphate on high-energy phosphate compounds during anoxia and reperfusion in isolated langendorff-perfused rat hearts.

  1991cited by this paper
• The effects of fructose-1,6-diphosphate on myocardial damage in acute coronary artery occlusion.

  1991cited by this paper
• Fructose 1-6 diphosphate prevents intestinal ischemic reperfusion injury and death in rats.

  1990cited by this paper
• Attenuation of ischemic renal injury with fructose 1,6-diphosphate.

  1989cited by this paper
• Some effects of fructose‐1,6‐diphosphate on rat myocardial tissue related to a membrane‐stabilizing action

  1989cited by this paper
• Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome.

  1986cited by this paper
• Fructose-1,6-diphosphate: an agent for treatment of experimental endotoxin shock.

  1981cited by this paper
• Primer of biostatistics : statistical software program version 6.0

  1981cited by this paper
• Measurement of free calcium ion in capillary blood and serum.

  1978cited by this paper

• Yinhuang buccal tablet alters airway microbiota composition and metabolite profile in healthy humans.

  2024cites this paper
• Synthesis of hydrophobically modified alginate and hydrophobically modified gelatin containing cubic phase for pH- and salt-responsive release of fructose diphosphate

  2022cites this paper
• Fructose 1,6-Bisphosphate: A Summary of Its Cytoprotective Mechanism.

  2016cites this paper
• Comparison of lactoferrin activity in fresh and stored human milk

  2016cites this paper
• Fructose-1,6-bisphosphate suppresses lipopolysaccharide-induced expression of ICAM-1 through modulation of toll-like receptor-4 signaling in brain endothelial cells.

  2015cites this paper
• Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question

  2014cites this paper
• Nitric oxide as a mediator of fructose 1,6-bisphosphate protection in galactosamine-induced hepatotoxicity in rats.

  2013cites this paper
• Fructose-1,6-bisphosphate ameliorates lipopolysaccharide-induced dysfunction of blood–brain barrier

  2013cites this paper
• Fructose-1,6-bisphosphate attenuates induction of nitric oxide synthase in microglia stimulated with lipopolysaccharide.

  2012cites this paper
• Fructose-1,6-bisphosphate Protects against Zymosan-induced Acute Lung Injury in Mice

  2012cites this paper
• Fructose-1,6-bisphosphate inhibits in vitro and ex vivo platelet aggregation induced by ADP and ameliorates coagulation alterations in experimental sepsis in rats

  2010cites this paper
• Investigação do aumento endógeno de adenosina decorrente da administração do intermediário glicolítico D-Frutose-1,6-difosfato

  2009cites this paper
• Effect of normothermic perfusion using fructose-1,6-bisphosphate for maintenance of liver function during in situ extended hepatectomy by the total hepatic vascular exclusion technique.

  2007cites this paper
• Fructose 1,6-diphosphate alleviates UV-induced oxidative skin damage in hairless mice.

  2007cites this paper
• METHODS FOR IMPROVING NEUROLOGICAL RECOVERY AFTER HYPOTHERMIC CIRCULATORY ARREST

  2005cites this paper
• Neuroprotection by fructose-1,6-bisphosphate involves ROS alterations via p38 MAPK/ERK.

  2004cites this paper
• Physiopathological studies in septic rats and the use of fructose 1,6-bisphosphate as cellular protection

  2002influential citation
• Fructose‐1,6‐diphosphate attenuates prostaglandin E2 production and cyclo‐oxygenase‐2 expression in UVB‐irradiated HaCaT keratinocytes

  2002cites this paper
• Storage solution containing fructose-1,6-bisphosphate inhibits the excess activation of kupffer cells in cold liver preservation1.

  2002influential citation
• Fructose-1,6-Bisphosphate Inhibits Excess Activation of Kupffer Cell Function Induced by Endotoxin

  2002cites this paper
• Effect of fructose-1, 6-diphosphate versus diphenhydramine on mortality in compound 48/80-induced shock.

  2001cites this paper
• Lactoferrin protects neonatal rats from gut-related systemic infection.

  2001cites this paper
• Fructose-1,6-bisphosphate inhibits the expression of inducible nitric oxide synthase caused by oxygen-glucose deprivation through the inhibition of glutamate release in rat forebrain slices

  2000cites this paper